Published in Drug Week, July 6th, 2001
The peptide vaccine was most effective when conjugated to diphtheria toxin (DT) with alum as adjuvant and is now ready for trial in humans, reported J.L. McAnally and colleagues at the University of Alabama, Birmingham.
"Myasthenia gravis (MG) and its animal model, experimental autoimmune (EA) MG, are caused by interference with neuromuscular transmission by auto-antibodies against the nicotinic acetylcholine receptor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.